Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma. (10th March 2022)
- Record Type:
- Journal Article
- Title:
- Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma. (10th March 2022)
- Main Title:
- Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma
- Authors:
- Kondo, Yasuto
Ichinose, Junji
Ninomiya, Hironori
Hashimoto, Kohei
Matsuura, Yosuke
Nakao, Masayuki
Ishikawa, Yuichi
Okumura, Sakae
Satoh, Yukitoshi
Mun, Mingyon - Abstract:
- Abstract: OBJECTIVES: This study aimed to evaluate the prognostic impact of the combination of epidermal growth factor receptor (EGFR) mutation and the presence of high-grade patterns (solid or micropapillary component) in resected stage I lung adenocarcinoma. METHODS: Patients who underwent curative resection for pathological stage I lung adenocarcinoma and EGFR mutation analysis were included in this study. The impact of the combination of EGFR mutation and the presence of >5% high-grade patterns on recurrence-free survival (RFS) was retrospectively analysed using Cox proportional hazards model and propensity score-matched analysis. RESULTS: Among the included 721 patients, EGFR mutations were positive in 380 (52.7%). In the EGFR-mutated group, cases with high-grade patterns showed poorer RFS than those without (5-year RFS, 77.7% vs 92.5%, P < 0.001), whereas there were no significant prognostic differences in the EGFR wild-type group (5-year RFS, 89.8% vs 88.2%, P = 0.807). Multivariable analyses revealed that the combination of EGFR mutations and the presence of high-grade patterns was associated with poor RFS (hazard ratio = 1.655, P = 0.035). Furthermore, EGFR mutation was associated with poor RFS in the group with high-grade patterns (hazard ratio = 2.108, P = 0.008). After propensity score matching, EGFR-mutated cases with high-grade patterns showed poorer RFS ( P = 0.028). CONCLUSIONS: The combination of EGFR mutation and the presence of high-grade patterns wasAbstract: OBJECTIVES: This study aimed to evaluate the prognostic impact of the combination of epidermal growth factor receptor (EGFR) mutation and the presence of high-grade patterns (solid or micropapillary component) in resected stage I lung adenocarcinoma. METHODS: Patients who underwent curative resection for pathological stage I lung adenocarcinoma and EGFR mutation analysis were included in this study. The impact of the combination of EGFR mutation and the presence of >5% high-grade patterns on recurrence-free survival (RFS) was retrospectively analysed using Cox proportional hazards model and propensity score-matched analysis. RESULTS: Among the included 721 patients, EGFR mutations were positive in 380 (52.7%). In the EGFR-mutated group, cases with high-grade patterns showed poorer RFS than those without (5-year RFS, 77.7% vs 92.5%, P < 0.001), whereas there were no significant prognostic differences in the EGFR wild-type group (5-year RFS, 89.8% vs 88.2%, P = 0.807). Multivariable analyses revealed that the combination of EGFR mutations and the presence of high-grade patterns was associated with poor RFS (hazard ratio = 1.655, P = 0.035). Furthermore, EGFR mutation was associated with poor RFS in the group with high-grade patterns (hazard ratio = 2.108, P = 0.008). After propensity score matching, EGFR-mutated cases with high-grade patterns showed poorer RFS ( P = 0.028). CONCLUSIONS: The combination of EGFR mutation and the presence of high-grade patterns was associated with recurrence in resected stage I lung adenocarcinoma. Histological subtypes, including minor components, should be considered when evaluating the risk of recurrence in patients with EGFR-mutated lung adenocarcinoma. Abstract : Lung cancer is the most common cause of cancer-related death worldwide, with 1 378 400 deaths reported annually. … (more)
- Is Part Of:
- Interactive cardiovascular and thoracic surgery. Volume 35:Number 2(2022)
- Journal:
- Interactive cardiovascular and thoracic surgery
- Issue:
- Volume 35:Number 2(2022)
- Issue Display:
- Volume 35, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 35
- Issue:
- 2
- Issue Sort Value:
- 2022-0035-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-03-10
- Subjects:
- Lung adenocarcinoma -- Epidermal growth factor receptor -- Recurrence -- Surgery -- Histological subtype
Chest -- Surgery -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
616.1 - Journal URLs:
- http://icvts.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/icvts/ivac062 ↗
- Languages:
- English
- ISSNs:
- 1569-9293
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4531.871920
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22569.xml